Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

NCT07719894 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)
Atherosclerosis

Interventions

DRUG: Cilostazol
DRUG: Aspirin

Sponsor

Seoul National University Bundang Hospital